Long-Term Hydroxychloroquine Therapy and Risk of Coronary Artery Disease in Patients with Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a chronic systemic inflammatory disease associated with a high prevalence of cardiovascular disease (CVD). Hydroxychloroquine (HCQ) is commonly used to control disease activity in patients with SLE. We evaluated its potential additional therapeutic effect for re...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Deng-Ho, Leong, Pui-Ying, Sia, Sung-Kien, Wang, Yu-Hsun, Wei, James Cheng-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616930/
https://www.ncbi.nlm.nih.gov/pubmed/31195632
http://dx.doi.org/10.3390/jcm8060796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616930/
https://www.ncbi.nlm.nih.gov/pubmed/31195632
http://dx.doi.org/10.3390/jcm8060796

Ejemplares similares